Innovation and invention in medical devices workshop summary

Detalles Bibliográficos
Autor Corporativo: Institute of Medicine (U.S.). Roundtable on Research and Development of Drugs, Biologics, and Medical Devices (-)
Otros Autores: Hanna, Kathi E. (-)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academy Press 2001.
Edición:1st ed
Colección:Compass series (Washington, D.C.)
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820321606719
Tabla de Contenidos:
  • ""Innovation and Invention In Medical Devices""; ""Copyright""; ""Preface""; ""Contents""; ""1 Introductory Overview ""; ""OVERVIEW""; ""CHALLENGES TO INNOVATION""; ""REGULATORY ISSUES""; ""PAYMENT ISSUES""; ""VALUE AND CONSEQUENCES FOR INNOVATION""; ""CONCLUSIONS""; ""2 Keynote Session ""; ""HISTORICAL PERSPECTIVE ON IOM'S ROLE IN PROVIDING A FORUM FOR DISCUSSION""; ""A REGULATORY PERSPECTIVE""; ""AN INDUSTRY PERSPECTIVE: CHALLENGES IN THE DEVELOPMENT AND REGULATION OF DRUG-DEVICE COMBINATION PRODUCTS""; ""AN EVALUATOR'S PERSPECTIVE""
  • ""INNOVATION AND INVENTION IN MEDICAL DEVICES: IMPLANTABLE DEFIBRILLATORS""""GENERAL DISCUSSION OF THE KEYNOTE SESSION""; ""3 The Nature of Medical Innovation ""; ""THE INNOVATIVE PROCESS FOR MEDICAL DEVICES: A NASA PERSPECTIVE""; ""Medical Device Case Studies""; ""Cardiac Monitor""; ""Heart Imaging System""; ""Heart Assist Pump""; ""Telemedicine Instrumentation Pack""; ""Pill Telemetry Technologies""; ""Benefits of the NASA Process""; ""ENDOVASCULAR DEVICES""; ""GENE ARRAYS""; ""INHALED INSULIN""; ""IMAGING THE MICROVASCULATURE""; ""GENERAL DISCUSSION OF THE NATURE OF MEDICAL INNOVATION""
  • ""4 Sources and Support of Medical Devices Innovation """"AN OVERVIEW OF PUBLIC AND PRIVATE FACTORS AFFECTING MEDICAL DEVICE INNOVATION""; ""THE FEDERAL RESEARCH ROLE""; ""THE FEDERAL REGULATORY ROLE""; ""THE ACADEMIC ROLE IN INNOVATION""; ""THE ACADEMIC HEALTH CENTER ENVIRONMENT""; ""THE ROLE OF SMALL MEDICAL COMPANIES""; ""THE ROLE OF LARGE MEDICAL COMPANIES""; ""THE ROLE OF PUBLIC AND PRIVATE CAPITAL""; ""GENERAL DISCUSSION OF SOURCES AND SUPPORT OF MEDICAL DEVICE INNOVATION""; ""5 The Challenges Ahead ""; ""UNMET CLINICAL NEEDS: CARDIOVASCULAR DISEASE""
  • ""UNMET CLINICAL NEEDS: CLINICAL TRIALS""""BARRIERS AND ISSUES IN DEVICE INNOVATION: REIMBURSEMENT""; ""GENERAL DISCUSSION OF THE CHALLENGES AHEAD""; ""6 Summary and Conclusions ""; ""Appendix A Workshop Agenda Roundtable on Research and Development of Drugs, Biologics, and Medical Devices""; ""AGENDA""; ""Opening Session""; ""Keynote Session""; ""Session I: The Nature of Medical Innovation""; ""Session II: Sources and Support of Medical Device Innovation""; ""Session III: The Challenges Ahead""; ""Summary and Conclusions""; ""Appendix B Speakers' Biographical Sketches ""
  • ""Appendix C Registered Participants ""